MAPT and Alzheimer disease: Taking into account that, during AD progression, 24-OH and SIRT1 levels decrease on the one hand, and on the other hand NFT accumulates, it appeared of interest to determine whether the loss of 24-OH and SIRT1 could be responsible for the hyperphosphorylation of tau.